FDA Warns 17 Companies for Selling Unapproved Alzheimer’s Drugs

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb on Monday announced agency action against 17 companies for selling unapproved Alzheimer’s treatments.

To View This Article:

Login

Subscribe To Drug Industry Daily